COLO 205 In Vitro High Content Screening (HCS) Assay

This assay is to provide COLO 205-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

COLO 205

Human

The COLO 205 cell line is made up of epithelial cells isolated in 1975 from ascitic fluid derived from a 70-year-old, White, male with colon cancer. The cells can be used for cancer and toxicology research.

Colorectal Adenocarcinoma; Colon Cancer

Oncology

In Vitro High Content Screening (HCS) Assay

COLO 205-cell based In Vitro High Content Screening (HCS) Assay

HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.

High-throughput Screening, High Content Screening and Reporter Gene Assays